Modern Retina | Ophthalmology News, Events & Expert Insights
WEBBy Peter J. McDonnell, MD. September 24th 2024. Study: Socioeconomic inequality linked to increased risk of AMD. By David Hutton. September 24th 2024. University of Arkansas for Medical Sciences receives $2.2 million grant to study efferocytosis in retinopathy. By Martin David Harp. September 23rd 2024. The sights of Stockholm.
NR600 retinal prosthesis: Safe with promising visual results
WEBOct 2, 2020 — The NR600 is a stand-alone implant without wires that traverse the eye wall. Dr Stalmans explained that the device uses the natural eye optics and the retinal natural signal processing to provide the patient with vision. In this study, a miniature chip was implanted in the retina and held in place in the sulcus with haptics resembling those of ...
Diagnosing and treating MacTel degenerative retinal disease
WEBAug 1, 2017 — Idiopathic macular telangiectasia (MacTel) is a degenerative retinal disease that was described by Gass and Oyakawa in 1982. 1. Later, Gass and Blodi identified three subtypes of the disease. 2 In 2006, Yannuzzi et al. proposed a classification that is commonly used: aneurysmal (type 1), perifoveal (type 2) and occlusive (type 3). 3 Type 1 ...
Distinction between lamellar holes and macular pseudoholes
WEBMar 12, 2018 — Dr. Thompson defined pseudomacular holes as a clinical diagnosis as seen via slit lamp biomicroscopy versus optical coherence tomography (OCT). “Use pseudomacular holes only to describe the biomicroscopic appearance,” he added. In contrast, a lamellar macular hole is defined by the appearance of the fovea via OCT.
Improving visual outcomes after 360° relaxing retinectomy
WEBAug 27, 2020 — The use of sub-silicone oil triamcinolone acetonide (TA) crystals during a 360° relaxing retinectomy for complex retinal detachments with advanced proliferative vitreoretinopathy (PVR) can reduce the incidence of complications and improve visual outcomes compared with the procedure without TA crystals, according to a study presented by Subhendu Kumar Boral, MD, DNB, Disha Eye Hospitals Pvt ...
Dealing with complications of silicone oil - Modern Retina
WEBSep 2, 2022 — Re-detachment after silicone oil removal is a major complication, with rates varying up to 30%. Suspected ERP and ERMs can be diagnosed by direct examination and OCT and removed when silicone oil is removed from the eye. Peripheral 360-degree laser retinopexy and scleral encircling band significantly diminish the rate of re-detachment.
Patient-assistance programs for AMD treatments - Modern Retina
WEBFeb 28, 2018 — Lucentis Access Solutions is another patient-assistance program from Genentech designed to provide patients with the medicine needed at a cost they can afford. Lucentis Access Solutions specialists can verify if a patient’s insurance covers AMD medication and determine out-of-pocket expenses. …
Utilizing Widefield SS-OCTA to evaluate diabetic retinopathy severity
WEBNov 11, 2021 — On October 10, 2021, John B. Miller, MD, presented his talk entitled, “ Evaluation of Nonperfusion Area and Other Vascular Metrics by Widefield SS-OCTA as Biomarkers of Diabetic Retinopathy Severity,” at the ASRS 39th Annual Scientific Meeting. Dr. Miller practices at Massachusetts Eye and Ear Infirmary, Retina Service.
Identifying biomarkers to predict diabetic retinopathy progression
WEBSep 1, 2020 — Chan. “The identification of functional and/or structural biomarkers to indicate the degree of retinal ischemia and neurodegeneration is essential for predicting DR progression prior to physical manifestations in the eye. Analysis of retinal layer thickness by OCT and functional evaluation by mfERG are two diagnostic tests that reflect ...
Perspectives on intravenous bevacizumab repackaged for …
WEBJun 15, 2022 — Typically, 70 to 80 separate aliquots are taken from one bevacizumab vial and repacked for intraocular use. This repetitive process opens the door to contamination; one of the most serious risks from contamination is bacterial endophthalmitis. Unfortunately, cases of endophthalmitis caused by repackaging of bevacizumab have been reported. 1,2.
Skip to content